Chelating agent inhibition of Trypanosoma cruzi epimastigotes In vitro
- 31 December 1995
- journal article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 60 (4), 277-288
- https://doi.org/10.1016/0162-0134(95)00027-5
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Treatment of chronic Chagas' disease with benznidazole: Clinical and serologic evolution of patients with long-term follow-upAmerican Heart Journal, 1994
- CHAGAS DISEASEInfectious Disease Clinics of North America, 1993
- The challenge of Chagas' disease chemotherapy: An update of drugs assayed against Trypanosoma cruziActa Tropica, 1993
- Chagas' diseaseClinical Microbiology Reviews, 1992
- 1-(Substituted)benzyl-5-aminoimidazole-4-carboxamides are potent orally active inhibitors ofTrypanosoma cruzi in miceCellular and Molecular Life Sciences, 1991
- Research for New Antichagasic Drugs.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- Interaction of benznidazole reactive metabolites with nuclear and kinetoplastic DNA, proteins and lipids fromTrypanosoma cruziCellular and Molecular Life Sciences, 1988
- New anti-protozoal agentsInternational Journal for Parasitology, 1987
- Role of iron in Trypanosoma cruzi infection of mice.Journal of Clinical Investigation, 1984
- Present status of chemotheraphy and chemoprophylaxis of human trypanosomiasis in the Western HemispherePharmacology & Therapeutics, 1979